A detailed history of Aia Group LTD transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Aia Group LTD holds 26,793 shares of RDY stock, worth $417,167. This represents 0.06% of its overall portfolio holdings.

Number of Shares
26,793
Previous 24,439 9.63%
Holding current value
$417,167
Previous $1.86 Million 14.29%
% of portfolio
0.06%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$75.41 - $84.21 $177,515 - $198,230
2,354 Added 9.63%
26,793 $2.13 Million
Q2 2024

Jul 31, 2024

BUY
$68.26 - $76.19 $821,167 - $916,565
12,030 Added 96.95%
24,439 $1.86 Million
Q1 2024

May 06, 2024

BUY
$67.36 - $77.59 $82,179 - $94,659
1,220 Added 10.9%
12,409 $910,000
Q2 2023

Jul 28, 2023

BUY
$53.34 - $63.11 $439,734 - $520,278
8,244 Added 279.93%
11,189 $706,000
Q4 2022

Jan 31, 2023

BUY
$51.15 - $57.45 $150,636 - $169,190
2,945 New
2,945 $152,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.59B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Aia Group LTD Portfolio

Follow Aia Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aia Group LTD with notifications on news.